32 related articles for article (PubMed ID: 4371765)
1. Proceedings: Behavioral effects of direct and indirect acting dopaminergic agonists.
Moore KE
Psychopharmacol Bull; 1974 Jul; 10(3):41-2. PubMed ID: 4419323
[No Abstract] [Full Text] [Related]
2. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra.
Price MT; Fibiger HC
Eur J Pharmacol; 1974 Dec; 29(2):249-52. PubMed ID: 4613562
[No Abstract] [Full Text] [Related]
3. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
Creese I; Iversen SD
Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
[No Abstract] [Full Text] [Related]
4. Dopaminergic supersensitivity in the striatum.
Ungerstedt U; Ljungberg T; Hoffer B; Siggins G
Adv Neurol; 1975; 9():57-65. PubMed ID: 167568
[No Abstract] [Full Text] [Related]
5. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
Moore KE
Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
[No Abstract] [Full Text] [Related]
6. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S
Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
[No Abstract] [Full Text] [Related]
7. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
8. [Neurochemical and neurophysiological organization of phenamine behavioral stereotypy (review of the literature)].
Arushanian EB
Farmakol Toksikol; 1977; 40(2):221-30. PubMed ID: 404184
[No Abstract] [Full Text] [Related]
9. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
Zigmond MJ; Stricker EM
Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
[No Abstract] [Full Text] [Related]
10. Central actions of dopa and dopamine.
Sourkes TL
Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
[No Abstract] [Full Text] [Related]
11. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
Glowinski J
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
